Trial site
Blood Diseases Hospital
- 13running trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers11 trials
- Acute myeloid leukaemia8 trials
- Acute lymphoblastic leukaemia3 trials
- Chronic myeloid leukaemia1 trial
- Phase
- Phase 33 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting12 trials
- Active, not recruiting1 trial
- Lead sponsor
- Institute of Hematology & Blood Diseases Hospital, China13 trials
Running trials
Recruiting
Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia
Recruiting
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Recruiting
Azacitidine + Venetoclax VS Azacitidineas Maintenance Therapy in AML
Recruiting
Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
Recruiting
Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL
Recruiting
Recruiting
Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
Recruiting
Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
Recruiting
Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
Active, not recruiting
HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML
Recruiting
Recruiting
Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers11 recruiting
- Acute myeloid leukaemia7 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- Chronic myeloid leukaemia1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026